Tunis, TUNISIA - 20 Nov `19Evaluation of the Efficacy of a Dermocosmetic Product

Official Title: Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo

In Brief: Comparative study, Lithium liposome  versus placebo in intra-individual study.

Ages Eligible: 18 Years and older 

Start Date: November 20, 2019

Completion Date (estimated): May 2020

Status: Enrolling by invitation

Study ID from ClinicalTrials.gov: NCT04171427
Other Study ID Numbers: 18E1721 

Location: Hbib thamer Hospital, Tunis, Tunisia

Contact: To learn more about this study, you or your doctor may contact Dr. Samy FENNICHE. Please refer to this study by its NCT number.

 

FAQOther Questions

  • Who is prone to vitiligo?

    Scientists know that some people are genetically predisposed to a specific group of autoimmune diseases – including generalized vitiligo – but do not know who and why.It doesn’t...

  • What tests should be done?

    A well-trained dermatologist should be able to diagnose vitiligo and distinguish it from contact leukoderma or more than twenty other conditions with similar skin appearance bas...

  • What is vitiligo?

    Vitiligo (pronounced vit-ill-EYE-go) is a relatively common skin disease characterized by smooth, white, painless spots or patches on various parts of the body and hairs above i...